INGALLS & SNYDER LLC

Overview

• HeadquartersNew York, United States²
• Legal formLimited Liability Company²
• LEIWM8HZVNQD6SIY7TWON61²
• StatusActive²
• LEI statusIssued and current²
• Registered address1 ROCKEFELLER PLAZA, 10020 New York, United States²
• Registered withCorporation and Business Entity Database (Division of Corporations, State Records and UCC, Department of State), 1695262²

See how the biggest companies compare on our leaderboards

Corporate structure

INGALLS & SNYDER LLC sits at the top of its group. 8 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (7 companies). Each entity in the chart links to its source.

Timeline

1. Jan 19, 1993Founded INGALLS & SNYDER LLC is founded²

Filings

20 filings to the SEC since October 2021: 20 other. The latest 20:

1. Aug 14, 202613F-HR EDGAR
2. May 13, 202613F-HR EDGAR
3. Feb 13, 202613F-HR EDGAR
4. Nov 7, 202513F-HR EDGAR
5. Jul 31, 202513F-HR EDGAR
6. May 12, 202513F-HR EDGAR
7. Jan 29, 202513F-HR EDGAR
8. Nov 14, 202413F-HR EDGAR
9. Jul 31, 202413F-HR EDGAR
10. May 13, 202413F-HR EDGAR
11. Jan 29, 202413F-HR EDGAR
12. Nov 2, 202313F-HR EDGAR
13. Jul 27, 202313F-HR EDGAR
14. May 9, 202313F-HR EDGAR
15. Jan 31, 202313F-HR EDGAR
16. Oct 21, 202213F-HR EDGAR
17. Aug 11, 202213F-HR EDGAR
18. May 9, 202213F-HR EDGAR
19. Feb 11, 202213F-HR EDGAR
20. Oct 27, 202113F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

INGALLS & SNYDER LLC has told the SEC it owns more than 5% of 7 companies, latest first (Schedules 13D and 13G).

• APPLIED ENERGETICS, INC.SCHEDULE 13G Feb 4, 2022 to Apr 23, 2026³
• MindWalkSCHEDULE 13G/A Jul 7, 2023 to Apr 23, 2026⁴
• OMEROS CORPSCHEDULE 13G/A Feb 4, 2022 to Apr 23, 2026⁵
• STRATUS PROPERTIES INCSCHEDULE 13G/A Feb 4, 2022 to Apr 23, 2026⁶
• Corcept TherapeuticsSCHEDULE 13G/A Feb 4, 2022 to Apr 21, 2026⁷
• DURECT CORPSCHEDULE 13G/A Mar 27, 2024 to Feb 21, 2025⁸
• Inuvo, Inc.SC 13D/A Nov 22, 2021⁹